DULAGLUTIDE
Stress Hyperglycemia
Emory Universityprotein_peptidePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Stress Hyperglycemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin The First Affiliated Hospital of Xiamen University | Phase 4 | BBB |
Saffron Birjand University of Medical Sciences | Phase 4 | BB |
Sitagliptin Dawn Smiley MD | Phase 4 | BB |
Exenatide Saint Luke's Health System | Phase 4 | BB |
Capecitabine Brigham and Women's Hospital | Phase 4 | BB |
View all 34 →
Same molecule, other indications
DULAGLUTIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →